Axon Enterprise, Inc. (AXON) stock
Close on Oct 30, 2026Market cap $34.75BP/E 177.5Yield –
Earnings
Axon Enterprise's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Axon Enterprise's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q3 FY2026ended Sep 30, 2026 | Nov 3, 2026Expected | – | – | – | – | – |
| Q2 FY2026ended Jun 30, 2026 | Aug 5, 2026after the close | $904.00M | +35.1% | $0.36 | $1.88 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 6, 2026after the close | $807.00M | +33.6% | $2.05 | $1.61 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 24, 2026after the close | $797.00M | +38.6% | $0.03 | $2.15 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 4, 2025after the close | $711.00M | +30.7% | -$0.03 | $1.17 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 4, 2025after the close | $669.00M | +32.7% | $0.44 | $2.12 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 7, 2025after the close | $604.00M | +31.0% | $1.08 | $1.41 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 25, 2025after the close | $575.00M | +33.1% | $1.67 | $2.08 | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 7, 2024after the close | $544.00M | +31.4% | $0.86 | $1.45 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 6, 2024after the close | $504.00M | +34.4% | $0.53 | $1.20 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 6, 2024after the close | $461.00M | +34.4% | $1.73 | $1.15 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 27, 2024after the close | $432.00M | +28.6% | $0.75 | $1.12 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 7, 2023after the close | $414.00M | +32.7% | $0.78 | $1.02 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 8, 2023after the close | $375.00M | +31.1% | $0.16 | $1.11 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 9, 2023after the close | $343.00M | +34.0% | $0.61 | $0.88 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 28, 2023after the close | $336.00M | +54.1% | $0.40 | $0.70 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 8, 2022after the close | $312.00M | +34.5% | $0.17 | $0.60 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 9, 2022after the close | $286.00M | – | $0.71 | $0.44 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 10, 2022after the close | $256.00M | – | $0.76 | $0.45 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 24, 2022after the close | $218.00M | – | -$0.19 | $0.46 | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 15, 2021after the close | $232.00M | – | $0.67 | $1.17 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 5, 2021after the close | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 6, 2021after the close | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Feb 25, 2021after the close | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Nov 5, 2020after the close | – | – | – | – | Filing |
| Q2 FY2020ended Jun 30, 2020 | Aug 6, 2020after the close | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Axon Enterprise's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| revenue growth | FY2026 | +32% – +34% | +30% – +32% | Raised | Aug 5, 2026 |
| Adjusted EBITDA marginnon-GAAP | FY2026 | 25.5% | 25.5% | Reaffirmed | Aug 5, 2026 |
| free cash flow | FY2026 | $450.00M | – | New | May 6, 2026 |
| CapEx | FY2026 | $160.00M – $190.00M | $160.00M – $190.00M | Reaffirmed | Aug 5, 2026 |
| operating cash flow | FY2026 | $600.00M | – | Narrowed | May 6, 2026 |
| stock-based compensation expense | FY2026 | $590.00M – $620.00M | $590.00M – $620.00M | Raised | Aug 5, 2026 |
| stock-based compensation expenses | FY2026 | $590.00M – $620.00M | – | Reaffirmed | May 6, 2026 |
| annual revenue | FY2028 | $6.00B | – | New | Feb 24, 2026 |
| Adjusted EBITDA marginsnon-GAAP | FY2028 | 28% | – | New | Feb 24, 2026 |
Guidance vs results
The last range Axon Enterprise gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | Revenue | $2.74B | $2.78BΣ4Q | Above range |
| Q4 FY2025 | Revenue | $750.00M – $755.00M | $797.00M | Above range |
| Q4 FY2024 | Revenue | $560.00M – $570.00M | $575.00M | Above range |
| Q4 FY2023 | Revenue | $417.00M – $420.00M | $432.00M | Above range |
| Q4 FY2022 | Revenue | $300.00M – $310.00M | $336.00M | Above range |
Guidance history
Every forecast Axon Enterprise put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Aug 5, 2026 | CapEx | FY2026 | $160.00M – $190.00M | Reaffirmed |
| Aug 5, 2026 | Adjusted EBITDA margin | FY2026 | 25.5% | Reaffirmed |
| Aug 5, 2026 | stock-based compensation expense | FY2026 | $590.00M – $620.00M | Raised |
| Aug 5, 2026 | revenue growth | FY2026 | +32% – +34% | Raised |
| May 6, 2026 | CapEx | FY2026 | $160.00M – $190.00M | Lowered |
| May 6, 2026 | free cash flow | FY2026 | $450.00M | New |
| May 6, 2026 | Adjusted EBITDA margin | FY2026 | 25.5% | Reaffirmed |
| May 6, 2026 | stock-based compensation expenses | FY2026 | $590.00M – $620.00M | Reaffirmed |
| May 6, 2026 | operating cash flow | FY2026 | $600.00M | Narrowed |
| May 6, 2026 | revenue growth | FY2026 | +30% – +32% | Raised |
| Feb 24, 2026 | Capital expenditures | FY2026 | $185.00M – $215.00M | New |
| Feb 24, 2026 | Adjusted EBITDA margin | FY2026 | 25.5% | New |
| Feb 24, 2026 | Adjusted EBITDA margins | FY2028 | 28% | New |
| Feb 24, 2026 | Stock-based compensation expense | FY2026 | $590.00M – $620.00M | New |
| Feb 24, 2026 | Revenue growth | FY2026 | +27% – +30% | New |
| Feb 24, 2026 | annual revenue | FY2028 | $6.00B | New |
| Nov 4, 2025 | CapEx | FY2025 | $170.00M – $180.00M | Lowered |
| Nov 4, 2025 | Adjusted EBITDA | Q4 FY2025 | $178.00M – $182.00M | New |
| Nov 4, 2025 | Adjusted EBITDA margin | FY2025 | 25% | Reaffirmed |
| Nov 4, 2025 | stock-based compensation expenses | FY2025 | $580.00M – $630.00M | Reaffirmed |
| Nov 4, 2025 | revenue outlook | FY2025 | $2.74B | Raised |
| Nov 4, 2025 | revenue | Q4 FY2025 | $750.00M – $755.00M | New |
| Aug 4, 2025 | CapEx | FY2025 | $170.00M – $185.00M | New |
| Aug 4, 2025 | Adjusted EBITDA dollars | FY2025 | $665.00M – $685.00M | New |
| Aug 4, 2025 | Adjusted EBITDA margin | FY2025 | 25% | New |
| Aug 4, 2025 | stock-based compensation expenses | FY2025 | $580.00M – $630.00M | New |
| Aug 4, 2025 | revenue | FY2025 | $2.65B – $2.73B | New |
| May 7, 2025 | CapEx | FY2025 | $160.00M – $180.00M | Raised |
| May 7, 2025 | Adjusted EBITDA dollars | FY2025 | $650.00M – $675.00M | Raised |
| May 7, 2025 | Adjusted EBITDA margin | FY2025 | 25% | New |
| May 7, 2025 | stock-based compensation expenses | FY2025 | $580.00M – $630.00M | Reaffirmed |
| May 7, 2025 | revenue | FY2025 | $2.60B – $2.70B | Raised |
| Feb 25, 2025 | CapEx | FY2025 | $140.00M – $180.00M | New |
| Feb 25, 2025 | Adjusted EBITDA dollars | FY2025 | $640.00M – $670.00M | New |
| Feb 25, 2025 | Adjusted EBITDA margin | FY2025 | 25% | Reaffirmed |
| Feb 25, 2025 | stock-based compensation expenses | FY2025 | $580.00M – $630.00M | New |
| Feb 25, 2025 | annual growth | FY2025 | +25% | New |
| Feb 25, 2025 | revenue | FY2025 | $2.55B – $2.65B | Raised |
| Nov 7, 2024 | CapEx | FY2024 | $80.00M – $95.00M | Reaffirmed |
| Nov 7, 2024 | Adjusted EBITDA | Q4 FY2024 | $130.00M – $135.00M | New |
| Nov 7, 2024 | Adjusted EBITDA dollars | FY2024 | $510.00M | Raised |
| Nov 7, 2024 | Adjusted EBITDA margin | Q4 FY2024 | 23.5% | New |
| Nov 7, 2024 | Adjusted EBITDA margin | FY2024 | 24.6% | Raised |
| Nov 7, 2024 | stock-based compensation expenses | FY2024 | $360.00M – $380.00M | Raised |
| Nov 7, 2024 | revenue | Q4 FY2024 | $560.00M – $570.00M | New |
| Nov 7, 2024 | revenue | FY2024 | $2.07B | Raised |
| Aug 6, 2024 | CapEx | FY2024 | $80.00M – $95.00M | Reaffirmed |
| Aug 6, 2024 | Adjusted EBITDA dollars | FY2024 | $460.00M – $475.00M | Raised |
| Aug 6, 2024 | stock-based compensation expenses | FY2024 | $355.00M – $370.00M | Raised |
| Aug 6, 2024 | revenue | FY2024 | $2.00B – $2.05B | Raised |
| May 6, 2024 | CapEx | FY2024 | $80.00M – $95.00M | Raised |
| May 6, 2024 | Adjusted EBITDA dollars | FY2024 | $430.00M – $445.00M | Raised |
| May 6, 2024 | Adjusted EBITDA margin | FY2024 | 22% | New |
| May 6, 2024 | stock-based compensation expenses | FY2024 | $215.00M – $230.00M | Raised |
| May 6, 2024 | revenue | FY2024 | $1.94B – $1.99B | New |
| Feb 27, 2024 | CapEx | FY2024 | $60.00M – $75.00M | New |
| Feb 27, 2024 | Adjusted EBITDA dollars | FY2024 | $410.00M – $430.00M | New |
| Feb 27, 2024 | stock-based compensation expenses | FY2024 | $205.00M – $220.00M | New |
| Feb 27, 2024 | revenue | FY2024 | $1.88B – $1.94B | New |
| Nov 7, 2023 | CapEx | FY2023 | $50.00M – $65.00M | Reaffirmed |
| Nov 7, 2023 | Adjusted EBITDA dollars | FY2023 | $322.00M | Raised |
| Nov 7, 2023 | Adjusted EBITDA margin | Q4 FY2023 | 20% | New |
| Nov 7, 2023 | stock-based compensation expenses | FY2023 | $130.00M – $140.00M | Lowered |
| Nov 7, 2023 | revenue | Q4 FY2023 | $417.00M – $420.00M | New |
| Nov 7, 2023 | revenue | FY2023 | $1.55B | Raised |
| Aug 8, 2023 | CapEx | FY2023 | $50.00M – $65.00M | Reaffirmed |
| Aug 8, 2023 | Adjusted EBITDA margin | FY2023 | 20% | New |
| Aug 8, 2023 | stock-based compensation expenses | FY2023 | $140.00M | Lowered |
| Aug 8, 2023 | revenue expectation | FY2023 | $1.51B – $1.53B | Raised |
| May 9, 2023 | CapEx | FY2023 | $50.00M – $65.00M | Reaffirmed |
| May 9, 2023 | implied Adjusted EBITDA | FY2023 | $288.00M – $292.00M | Raised |
| May 9, 2023 | Adjusted EBITDA margin | FY2023 | 20% | Reaffirmed |
| May 9, 2023 | stock-based compensation expense | FY2023 | $141.00M | Raised |
| May 9, 2023 | revenue | FY2023 | $1.44B – $1.46B | New |
| Feb 28, 2023 | CapEx | FY2023 | $50.00M – $65.00M | New |
| Feb 28, 2023 | Adjusted EBITDA | FY2023 | $286.00M | New |
| Feb 28, 2023 | adjusted free cash flow conversion on Adjusted EBITDA | FY2025 | 60% | New |
| Feb 28, 2023 | Adjusted EBITDA margin | FY2023 | 20% | New |
| Feb 28, 2023 | stock-based compensation expense | FY2023 | $140.00M | New |
| Feb 28, 2023 | CAGR for annual dilution | FY2025 | 3% | New |
| Feb 28, 2023 | Adjusted EBITDA margins | FY2025 | 25% | New |
| Feb 28, 2023 | revenue | FY2023 | $1.43B | New |
| Feb 28, 2023 | Revenue | FY2025 | $2.00B | New |
| Nov 8, 2022 | capital expenditures | FY2022 | $70.00M – $80.00M | Lowered |
| Nov 8, 2022 | Adjusted EBITDA | Q4 FY2022 | $49.00M – $54.00M | New |
| Nov 8, 2022 | Adjusted EBITDA | FY2022 | $215.00M – $220.00M | Raised |
| Nov 8, 2022 | stock-based compensation expense | FY2022 | $105.00M | New |
| Nov 8, 2022 | revenue | Q4 FY2022 | $300.00M – $310.00M | New |
| Nov 8, 2022 | revenue | FY2022 | $1.15B – $1.16B | Raised |
| Aug 9, 2022 | capital expenditures | FY2022 | $80.00M – $90.00M | Lowered |
| Aug 9, 2022 | Adjusted EBITDA | FY2022 | $190.00M – $200.00M | Reaffirmed |
| Aug 9, 2022 | adjusted free cash flow | FY2022 | $125.00M – $145.00M | Reaffirmed |
| Aug 9, 2022 | revenue | FY2022 | $1.07B – $1.12B | Raised |
| May 10, 2022 | capital expenditures | FY2022 | $135.00M – $160.00M | New |
| May 10, 2022 | Adjusted EBITDA | FY2022 | $190.00M – $200.00M | Raised |
| May 10, 2022 | adjusted free cash flow | FY2022 | $125.00M – $145.00M | Reaffirmed |
| May 10, 2022 | revenue | FY2022 | $1.05B – $1.10B | Raised |
| Feb 24, 2022 | capital expenditures | FY2022 | $135.00M – $160.00M | New |
| Feb 24, 2022 | Adjusted EBITDA | FY2022 | $185.00M – $195.00M | New |
| Feb 24, 2022 | adjusted free cash flow | FY2022 | $125.00M – $145.00M | New |
| Feb 24, 2022 | revenue | FY2022 | $1.04B | New |
| Nov 15, 2021 | capital expenditures | FY2021 | $65.00M – $70.00M | New |
| Nov 15, 2021 | Adjusted EBITDA | FY2021 | $163.00M – $168.00M | New |
| Nov 15, 2021 | stock-based compensation expense | FY2021 | $300.00M | New |
| Nov 15, 2021 | revenue | FY2021 | $850.00M | New |
| Nov 15, 2021 | revenue | FY2022 | $1.00B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Axon Enterprise filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Update
- Results
- Results
- Results
- Results
- Results
- Results
- News
- News
- News
- Results
- Results
- Results
- Results